CD8A and neoplasm: Above, we demonstrated that TRP2 T cells failed to kill CT2A-TRP2-β2mKO tumor cells in vitro (Fig. 1d), confirming that CD8+ T cells alone cannot kill MHC-I-negative tumors, even in the presence of a cognate antigen.